RESUMO
OBJECTIVE: Diarrheal diseases are a leading cause of morbidity and mortality worldwide, but the etiology of diarrhea and its relation to nutritional outcomes in resource-limited settings is poorly defined. We sought to determine the etiology of community-acquired diarrhea in Tanzanian infants and to assess the association with anthropometrics and novel intestinal biomarkers. METHODS: A convenience sample of infants in a trial of zinc and/or multivitamin supplementation in Tanzania was selected. Subjects were enrolled at age 6 weeks and studied for 18 months. Stool samples were obtained from children with acute diarrhea. A novel, polymerase chain reaction-based TaqMan array was used to screen stool for 15 enteropathogens. A subset of subjects had serum gastrointestinal biomarkers measured. RESULTS: One hundred twenty-three subjects with diarrhea were enrolled. The mean ± SD age at stool sample collection was 12.4â±â3.9 months. Thirty-five enteropathogens were identified in 34 (27.6%) subjects: 11 rotavirus, 9 Cryptosporidium spp, 7 Shigella spp, 3 Campylobacter jejuni/coli, 3 heat stable-enterotoxigenic Escherichia coli, and 2 enteropathogenic E coli. Subjects with any identified enteropathogen had significantly lower weight-for-length z scores (-0.55â±â1.10 vs 0.03â±â1.30, Pâ=â0.03) at the final clinic visit than those without an identified pathogen. Fifty of the 123 subjects (40.7%) had serum analyzed for antibodies to lipopolysaccharide (LPS) and flagellin. Subjects with any identified enteropathogen had lower immunoglobulin (IgA) antibodies to LPS (0.75â±â0.27 vs 1.13â±â0.77, Pâ=â0.01) and flagellin (0.52â±â0.16 vs 0.73â±â0.47, Pâ=â0.02) than those without an identified pathogen. CONCLUSIONS: This quantitative polymerase chain reaction method may allow identification of enteropathogens that place children at higher risk for suboptimal growth. IgA anti-LPS and flagellin antibodies hold promise as emerging intestinal biomarkers.
Assuntos
Diarreia/etiologia , Flagelina/imunologia , Microbioma Gastrointestinal , Transtornos do Crescimento/etiologia , Imunoglobulina A/sangue , Intestinos , Lipopolissacarídeos/imunologia , Biomarcadores/sangue , Peso Corporal , Campylobacter/crescimento & desenvolvimento , Cryptosporidium/crescimento & desenvolvimento , Diarreia/microbiologia , Diarreia/parasitologia , Diarreia/virologia , Escherichia coli Enteropatogênica/crescimento & desenvolvimento , Fezes/microbiologia , Fezes/parasitologia , Fezes/virologia , Feminino , Transtornos do Crescimento/microbiologia , Transtornos do Crescimento/parasitologia , Transtornos do Crescimento/virologia , Humanos , Lactente , Infecções/complicações , Enteropatias/complicações , Intestinos/microbiologia , Intestinos/parasitologia , Intestinos/virologia , Masculino , Estado Nutricional , Reação em Cadeia da Polimerase , Rotavirus/crescimento & desenvolvimento , Shigella/crescimento & desenvolvimento , TanzâniaRESUMO
OBJECTIVES: We sought to determine whether serum citrulline (CIT), an amino acid produced by small bowel enterocytes, was associated with clinical and biochemical markers of gastrointestinal function in children undergoing hematopoietic cell transplantation (HCT). METHODS: We conducted a multicenter, prospective cohort study of 26 children to define time-related changes in serum CIT during the course of HCT. Markers of gastrointestinal function including oral energy intake, emesis, stool volume, presence of graft-versus-host disease (GVHD), oral mucositis severity, and cytokine and neurohormone levels were measured. Weekly serum CIT concentrations were obtained from 10 days prior until 30 days after HCT. RESULTS: Mean baseline CIT concentration was 22.7âµmol/L (95% confidence interval [CI] 17.7-27.6) on day -10, which decreased to a nadir of 7.5âµmol/L (95% CI 3.1-18.0, Pâ=â0.017) on day 8 following HCT before returning to baseline by day 30. After adjustment for IL-6 level (1.0% lower CIT per 10% increase in interleukin-6, Pâ=â0.004), presence of acute GVHD (27% lower CIT, Pâ=â0.025), and oral energy intake (2.1% lower CIT per 10% decrease in energy intake, Pâ=â0.018), the nadir shifted to day 10, when mean CIT concentration was lower in patients with severe oral mucositis (6.7âµmol/L, 95% CI 3.4-13.1) than in those without severe mucositis (11.9âµmol/L, 95% CI 5.8-24.4, Pâ=â0.003). Change in CIT was not correlated with stool volume, C-reactive protein, tumor necrosis factor-α, leptin, or ghrelin. CONCLUSIONS: In children undergoing HCT, serum CIT correlates with measures of gastrointestinal function (oral mucositis severity, dietary intake, acute GVHD) and may reflect mucosal injury to the gastrointestinal tract.
Assuntos
Citrulina/sangue , Ingestão de Energia , Doença Enxerto-Hospedeiro/sangue , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Mucosa Bucal/patologia , Mucosite/sangue , Adolescente , Biomarcadores/sangue , Criança , Doença Enxerto-Hospedeiro/etiologia , Humanos , Interleucina-6/sangue , Masculino , Mucosite/etiologia , Estudos ProspectivosRESUMO
Recessive dystrophic epidermolysis bullosa (EB) is a rare disease characterized by painful blistering and erosion of the skin, sometimes referred to as "butterfly skin disease" because patients' skin becomes as fragile as butterfly wings. In addition to severe dermatologic manifestations, EB patients also experience complications affecting epithelial surfaces including the gastrointestinal tract. While gastrointestinal complications such as oral mucosal ulceration, esophageal strictures, constipation, and gastroesophageal reflux are common in EB patients, reports of colitis are rare. Here we describe a patient with recessive dystrophic EB who developed EB-associated colitis. This case highlights the diagnostic challenges as well as the gaps in our current understanding of the prevalence, pathogenesis, and treatment of EB-associated colitis.